Jan 13 2010
ResearchPoint Global (RPG) announces its newest member, GVK
Biosciences (GVK BIO), an India-based, full-service Contract Research
Organization (CRO). A leading CRO in Asia, GVK BIO provides
RPG with access to an extensive network of experienced and proven
investigative sites and country-specific regulatory, clinical and
technical expertise.
“Our existing clients will benefit from our
ability to recruit patients across multiple geographies through RPG.”
As the growth of India’s participation in global clinical research
and development continues to increase at a rapid pace, RPG strategically
sought to expand its reach to this region. According to The Goldman
Sachs Group, Inc., “India presents an attractive region for clinical
trials given a population of over one billion, a large number of
English-speaking patients, and a well developed information technology
industry.”
RPG’s expansion into India offers numerous advantages for running
clinical trials: a large population, qualified medical personnel, and
well-established regulations. GVK BIO complements RPG’s current presence
in the Americas, Europe (Western, Central, and Eastern) and Africa.
“RPG is strategically expanding our global footprint with
qualified, like-minded CROs who have extensive drug development
experience across a broad range of therapeutic areas,” said Matt Walker,
Executive Vice President of Marketing and Business Development with
ResearchPoint, a member of RPG. “GVK Biosciences has built
an exceptional reputation as a full-service clinical service provider in
India and we look forward to leveraging their deep local knowledge for
the benefit of our clients.”
“GVK Biosciences expands upon the ResearchPoint Global objective
of providing Sponsors with the ability to conduct international studies,
knowing that they have best-in-class teams who have successfully
executed studies in their local market, fulfilling our promise to
provide global capabilities with local expertise,” noted Paul
Braconnier, Governing Board Member of RPG.
Manni Kantipudi, President, GVK BIO commented, “We are pleased to
be part of ResearchPoint Global. This partnership enables GVK BIO to
participate in global trials while focusing on local
investigators/recruitment and leveraging lower local costs. While both
ResearchPoint Global and GVK BIO are full service CROs offering services
independently, together, we hope to offer faster patient
recruitment and access to our complete suite of functional services
including Clinical Data Management, Medical Writing, and Biostatistics.”
“With our experience in several therapeutic areas, extensive
investigator network, local regulatory expertise, and medical affairs
capabilities, we are confident in bringing value to RPG," noted Shoibal
Mukjherjee, Senior Vice President & Head of Clinical Development, GVK
BIO. "Our existing clients will benefit from our
ability to recruit patients across multiple geographies through RPG.”